Brown Brothers Harriman & Co’s PRA Health Sciences, Inc. PRAH Stock Holding History

Brown Brothers Harriman & Co’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4	Closed	-$1	–	1252
2021 Q2	$1	Hold	4	–	–	﹤0.01%	1149
2021 Q1	$1	Buy	+4	New	+$543	﹤0.01%	1089
2017 Q1	–	Sell	-87	Closed	-$5K	–	909
2016 Q4	$5K	Hold	87	–	–	﹤0.01%	771
2016 Q3	$5K	Hold	87	–	–	﹤0.01%	695
2016 Q2	$4K	Buy	+87	New	+$4.01K	﹤0.01%	745

Other funds holding PRAH

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Brown Brothers Harriman & Co's PRAH Position: Q3 2021 in Review

Brown Brothers Harriman & Co sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 4 shares — an estimated $1 sold.

Brown Brothers Harriman & Co first reported a position in PRAH in Q2 2016 and held it in 5 quarters. The position peaked at $5K in Q4 2016. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

Brown Brothers Harriman & Co reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
Brown Brothers Harriman & Co sold 4 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.
Brown Brothers Harriman & Co first reported a position in PRA Health Sciences, Inc. in Q2 2016 and held it in 5 quarters.
Brown Brothers Harriman & Co's PRA Health Sciences, Inc. position peaked at $5K in Q4 2016.
1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Brown Brothers Harriman & Co's 13F filing for Q3 2021, filed 15 Nov 2021.